Image Results
No matches found.
Video Results
No matches found.
Web Results
First | Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next | Last
Integrin Inhibitors For Targeting Cancer (Search Map)
Cilengitide is the first in a new class of investigational targeted anti-cancer therapiesâ€"called integrin inhibitorsâ€"to reach Phase 3 development.
PLoS ONE : accelerating the publication of peer-reviewed science (Search Map)
A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone ...
SEQT - Noticias Destacadas (Search Map)
Sociedad Española de Química Terapéutica ... the pentapeptide antiangiogenic integrin antagonist cilengitide (EMD-121974; Merck KGaA) was administered as a continuous ...
Phase I clinical trial of cilengitide in children with ... (Search Map)
PURPOSE: A phase I trial of the antiangiogenesis agent cilengitide (EMD 121974), an alpha v beta 3,5 integrin antagonist, was performed to estimate ...
Sigmund H. Hsu, MD (Search Map)
Cilengitide (EMD 121974) is a new peptide-based chemical entity with angiogenesis ... Agents such as EMD 121974 have the potential to suppress glioblastoma ...
Drug/Important Bio-Agent (IBA) - em Index | CureHunter (Search Map)
EMD 121974. EMD 122946. EMD 15700. EMD 16,923. EMD 16-795. EMD 16795. EMD ... 921. EMD 51921. EMD 52692. EMD 527040. EMD 53998. EMD 56133. EMD 56431. EMD 57033 ...
Pipeline Insight: Innovative Therapies - Targeted therapy, a ... (Search Map)
A convergence of scientific advances has enabled the identification of molecular targets specific to cancer cells, resulting in therapies with enhanced selectivity, ...
Novel Agents on the Horizon for Cancer Therapy -- Ma and ... (Search Map)
Cilengitide (EMD-121974) vβ3. Phase II (brain, head and neck, leukemia, melanoma, prostate) E-7820. 2. Phase I. Peptidomimetics. S247. vβ3. Preclinical. Return to article ...
Sloan-Kettering - Pediatric Brain Tumors: Our Clinical Trials (Search Map)
Press Releases In the News Information for Journalists News@MSKCC ... A Study of Cilengitide (EMD 121974) in Recurrent or Progressive and Refractory Childhood High-Grade Glioma ...
United States Court of Appeals for the Federal Circuit (Search Map)
Cancer Institute agreed to sponsor clinical trials for EMD 121974. ... the two RGD peptides other than EMD 121974 are not within the FDA Exemption ...
First | Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next | Last